Sign up to save your podcasts
Or
Share AI Bubble or Biggest Opportunity Yet? | July 6, 2026
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
AI Bubble or Biggest Opportunity Yet? | July 6, 2026
From LIVE Wall Street Beats July 6, 2026 show @10am ET
Is the AI trade becoming dangerously overcrowded? Is healthcare about to take the lead? And could investors be repeating one of history’s biggest market mistakes?
On this episode of Wall Street Beats, Ben Brey explains why today’s AI boom reminds him of the British Railway Mania—one of the greatest speculative bubbles ever—and why revolutionary technology doesn’t always produce winning investments.
David Maris makes the case that healthcare and biotech may be the market’s most overlooked opportunities heading into earnings season. He breaks down the latest on GLP-1 drugs, HIMS, Teladoc, and the surge in biotech acquisitions, while explaining why smart money may already be rotating beneath the surface.
As earnings season approaches, the team discusses where capital is flowing, what investors may be missing, and the biggest risks—and opportunities—that could shape the second half of the year.
Subscribe to get more stock analysis and insights from the Beats Roundtable pros.
Want more? Become a member. Join the Inner Circle and get a Seat at the Roundtable now:
wallstreetbeats.com
for exclusive access to our pros.
Disclaimer
This content has been produced by Street Beats Media, LLC (“Street Beats”) and is presented for informational purposes only. Street Beats is not a broker dealer and does not provide investment advice to individuals. None of the information contained herein constitutes an offer to sell, or solicitation of an offer to buy any security or investment vehicle, nor does it constitute an investment recommendation or legal, tax, accounting, or investment advice by Street Beats or any of its employees, officers, or agents. This information is presented without regard for individual investment preferences or risk parameters and is general, non-tailored, non-specific information. Our content is based on information from sources believed to be reliable. Street Beats is not responsible for errors, inaccuracies, or omissions of information. The opinions and conclusions contained in this content are those of the individual expressing those opinions or conclusions and are intended solely for the use by Street Beats subscribers and the authorized recipients of the content. All investments involve a certain degree of risk and financial instrument prices can fluctuate based on several factors, including those not considered in the preparation of this content. Consult a financial professional before investing.
View all episodes
By Wall Street BeatsFrom LIVE Wall Street Beats July 6, 2026 show @10am ET
Is the AI trade becoming dangerously overcrowded? Is healthcare about to take the lead? And could investors be repeating one of history’s biggest market mistakes?
On this episode of Wall Street Beats, Ben Brey explains why today’s AI boom reminds him of the British Railway Mania—one of the greatest speculative bubbles ever—and why revolutionary technology doesn’t always produce winning investments.
David Maris makes the case that healthcare and biotech may be the market’s most overlooked opportunities heading into earnings season. He breaks down the latest on GLP-1 drugs, HIMS, Teladoc, and the surge in biotech acquisitions, while explaining why smart money may already be rotating beneath the surface.
As earnings season approaches, the team discusses where capital is flowing, what investors may be missing, and the biggest risks—and opportunities—that could shape the second half of the year.
Subscribe to get more stock analysis and insights from the Beats Roundtable pros.
Want more? Become a member. Join the Inner Circle and get a Seat at the Roundtable now:
wallstreetbeats.com
for exclusive access to our pros.
Disclaimer
This content has been produced by Street Beats Media, LLC (“Street Beats”) and is presented for informational purposes only. Street Beats is not a broker dealer and does not provide investment advice to individuals. None of the information contained herein constitutes an offer to sell, or solicitation of an offer to buy any security or investment vehicle, nor does it constitute an investment recommendation or legal, tax, accounting, or investment advice by Street Beats or any of its employees, officers, or agents. This information is presented without regard for individual investment preferences or risk parameters and is general, non-tailored, non-specific information. Our content is based on information from sources believed to be reliable. Street Beats is not responsible for errors, inaccuracies, or omissions of information. The opinions and conclusions contained in this content are those of the individual expressing those opinions or conclusions and are intended solely for the use by Street Beats subscribers and the authorized recipients of the content. All investments involve a certain degree of risk and financial instrument prices can fluctuate based on several factors, including those not considered in the preparation of this content. Consult a financial professional before investing.